Asia Pacific Drug Development Market 2030: Navigating Regulatory Changes
Asia Pacific Drug Development Market Growth & Trends The Asia Pacific drug development market size is expected to reach USD 75.06 billion in 2030 and is projected to grow at a CAGR of 6.3% from 2024 to 2030. Challenges pertaining to the escalating research costs and shrinking revenue faced by major pharma companies have led to the significant expansion of Asian drug development sector. A rapidly expanding healthcare infrastructure, low operating costs, and a growing patient population have contributed to the recognition of Asian countries as an ideal site for low-cost drug development. Furthermore, the growing acceptance of clinical trial data generated in Asia by Western drug regulators, including the EMA and U.S. FDA, is one of the key market drivers. This is primarily because of the increasing similarities of Asian disease demographics to that of the Western nations. Gather more insights about the market drivers, restrains and growth of the Asia Pacific Drug Develop...